Synopsis: AIG Hospitals has introduced India’s first affordable pharmacogenomic testing, after after discovering that that nearly 30 percent of patients respond poorly to standard prescriptions due to genetic differences, including a key enzyme affecting heart, diabetes, and ulcer medications. The test analyses 120 genes from a small blood sample, producing a lifelong personalised report that guides doctors on which drugs and dosages will work safely and effectively for each patient, bridging the gap between Western textbook prescriptions and Indian genetics.

The cardiac patient had done everything right. He underwent surgery. Took Clopidogrel faithfully after the procedure to prevent stent blockages. Followed every instruction.

Then he suffered a heart attack anyway.

“We often see p

See Full Page